Literature DB >> 16713447

Sex-specific regulation of growth plate chondrocytes by estrogen is via multiple MAP kinase signaling pathways.

J McMillan1, S Fatehi-Sedeh, V L Sylvia, V Bingham, M Zhong, B D Boyan, Z Schwartz.   

Abstract

Both male and female rat growth plate cartilage cells possess estrogen receptors (ERs), but 17beta-estradiol (E(2)) activates protein kinase C (PKC) and PKC-dependent biological responses to E(2) only in cells from female animals. PKC signaling can elicit genomic responses via mitogen activated protein kinase (MAPK) and E(2) has been shown to activate ERK MAPK in many cells, suggesting that MAPK may play a role in growth plate chondrocytes as well. We tested if E(2) increases MAPK activity and if so, whether the response is limited to female cells, if it is PKC-dependent, and if the mechanism involves traditional ER pathways. We also determined the contribution of MAPK to the biological response of growth plate chondrocytes and assessed the relative contributions of ERK, p38 and JNK MAPKs. Female rat costochondral cartilage cells were treated with E(2) and MAPK-specific activity determined in cell layer lysates. The mechanism of MAPK activation was determined by treating the cells with E(2) conjugated to bovine serum albumin (E(2)-BSA) to assess if membrane receptors were involved; stereospecificity was determined using 17alpha-estradiol; PKC and phospholipase C (PLC) dependence was determined using specific inhibitors; and the ER agonist diethylstilbestrol, the ER antagonist ICI 182780, and tamoxifen were used to assess the role of traditional ER pathways. E(2) regulation of ERK1/2 MAPK was assessed and the relative roles of ERK1/2, p38 and JNK MAPKs determined using specific inhibitors. E(2) caused a rapid dose-dependent activation of MAPK that was greatest in cells treated for 9 min with 10(-9) M hormone; activity remained elevated for 3 h. E(2)'s effect on MAPK was stereospecific and comparable to that of E(2)-BSA. It was insensitive to DES and ICI 182780, dependent on PKC and PLC, blocked by tamoxifen and it did not require gene transcription or translation. E(2) had no effect on ERK1 or ERK2 mRNA or protein but it caused a rapid phosphorylation of ERK1/2 at 9 min. Inhibition of ERK1/2 and p38 MAPK reduced the stimulatory effects of E(2) on alkaline phosphatase activity and [(35)S]-sulfate incorporation. These results suggest that E(2) regulates MAPK through a sex-specific membrane-mediated mechanism that does not involve cytosolic ERs in a traditional sense and that ERK1/2 and p38 mediate the downstream biological effects of the hormone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16713447     DOI: 10.1016/j.bbamcr.2006.02.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Proceedings from the scientific symposium: Sex differences in cardiovascular disease and implications for therapies.

Authors:  C Noel Bairey Merz; Saralyn Mark; Barbara D Boyan; Alice K Jacobs; Prediman K Shah; Leslee J Shaw; Doris Taylor; Eduardo Marbán
Journal:  J Womens Health (Larchmt)       Date:  2010-06       Impact factor: 2.681

2.  Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36).

Authors:  Reyhaan A Chaudhri; Rene Olivares-Navarrete; Natalia Cuenca; Agreen Hadadi; Barbara D Boyan; Zvi Schwartz
Journal:  J Biol Chem       Date:  2012-01-13       Impact factor: 5.157

Review 3.  Sex and gender considerations in male patients with osteoporosis.

Authors:  Christopher J Dy; Lauren E Lamont; Quang V Ton; Joseph M Lane
Journal:  Clin Orthop Relat Res       Date:  2011-07       Impact factor: 4.176

4.  Genomic priming of the antisecretory response to estrogen in rat distal colon throughout the estrous cycle.

Authors:  Fiona O'Mahony; Rodrigo Alzamora; Ho-Lam Chung; Warren Thomas; Brian J Harvey
Journal:  Mol Endocrinol       Date:  2009-10-21

5.  Bone plasticity in response to exercise is sex-dependent in rats.

Authors:  Wagner S Vicente; Luciene M dos Reis; Rafael G Graciolli; Fabiana G Graciolli; Wagner V Dominguez; Charles C Wang; Tatiana L Fonseca; Ana P Velosa; Hamilton Roschel; Walcy R Teodoro; Bruno Gualano; Vanda Jorgetti
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

Review 6.  The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors.

Authors:  Yu Gu; Tianxiang Chen; Elena López; Weizhu Wu; Xiangdong Wang; Jiang Cao; Lisong Teng
Journal:  J Transl Med       Date:  2014-01-21       Impact factor: 5.531

Review 7.  Osteoarthritis associated with estrogen deficiency.

Authors:  Jorge A Roman-Blas; Santos Castañeda; Raquel Largo; Gabriel Herrero-Beaumont
Journal:  Arthritis Res Ther       Date:  2009-09-21       Impact factor: 5.156

8.  Do sex steroids exert sex-specific and/or opposite effects on gene expression in lacrimal and meibomian glands?

Authors:  David A Sullivan; Roderick V Jensen; Tomo Suzuki; Stephen M Richards
Journal:  Mol Vis       Date:  2009-08-10       Impact factor: 2.367

9.  Hormonal modulation of connective tissue homeostasis and sex differences in risk for osteoarthritis of the knee.

Authors:  Barbara D Boyan; David A Hart; Roger M Enoka; Daniel P Nicolella; Eileen Resnick; Karen J Berkley; Kathleen A Sluka; C Kent Kwoh; Laura L Tosi; Mary I O'Connor; Richard D Coutts; Wendy M Kohrt
Journal:  Biol Sex Differ       Date:  2013-02-04       Impact factor: 5.027

10.  Characterization of osteoarthritic human knees indicates potential sex differences.

Authors:  Qingfen Pan; Mary I O'Connor; Richard D Coutts; Sharon L Hyzy; Rene Olivares-Navarrete; Zvi Schwartz; Barbara D Boyan
Journal:  Biol Sex Differ       Date:  2016-06-02       Impact factor: 5.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.